Built for FDA-regulated industries

RAi — your AI co-author for FDA submissions.

RAi stands for Regulatory Affairs Intelligence (pronounced "ray"). RAi drafts your 510(k), De Novo, PMA, and IND sections; catches FDA-risky language as you write; auto-cites every claim from your standards library and your own evidence; and tracks every submission through the FDA review lifecycle. A Clemtech Medical Solutions product.

🚀 Try the app
💼
Need regulatory consulting alongside the AI? Clemtech Medical pairs RAi with hands-on RA/QA expertise → clemtechmedical.com
LIVE
RA Director
Is our AI-based lesion detection algorithm a Class II 510(k) or a De Novo?
RAi
Likely 510(k) Class II if you can identify a legally marketed predicate with the same intended use and technological characteristics. Candidates: K203258 (Aidoc BriefCase), K213567 (Viz.ai LVO). If your output differs (e.g., quantitative scoring vs. binary flag), De Novo may be required.
21 CFR 807.92
FDA AI/ML Action Plan
🩺
Medical devices
510(k), De Novo, PMA, QSR
💊
Pharma & biotech
IND, NDA, BLA, GMP
🤖
AI/ML SaMD
PCCP, GMLP, SaMD risk
📋
RA consultancies
Multi-client workflows

See it think.

Pick a scenario on the left. RAi answers like a senior regulatory consultant — citing the exact regulation, guidance document, or your internal SOP.

RAi · Regulatory Copilot
Reading from 4 connected sources · Last sync 2 min ago
Online
✨ Try clicking a scenario on the left, or type your own question below

Four pillars. One product. No more $300/hour for things AI can do in 30 seconds.

RAi is a real co-author, not a chatbot. It writes alongside you, watches for FDA pitfalls, traces every claim back to evidence, and shows you exactly where your submission stands.

📝

AI Co-Author

Drafts your 510(k), De Novo, PMA, IND, NDA, and BLA sections from your evidence — your test reports, SOPs, predicate K-numbers, and design history. Every paragraph is yours to accept, reword, or reject.

🛡️

RAi Guard — Pitfall Check

Catches FDA-risky language as you type. "Safe and effective" claims without evidence. Off-label implications. Vague timing. PCCP overreach. Each flag includes the FDA citation and a suggested rewording — accept it with one click.

📚

Citation Suggester

Drag a fact into the doc and RAi finds the standard that supports it — 21 CFR, ISO 14971, IEC 62304, ASTM, USP — plus your own test reports and SOPs. Accept the cite and the design controls traceability matrix updates automatically.

📊

Submission Tracker

Live progress bar through every FDA phase. Pre-Sub, RTA, substantive review, AI Hold (with clock pause), decision. Readiness score per section. Predicted decision date. The dashboard your CEO and board have been asking for.

📋

Built-in QMS — or built from scratch

Don't have a QMS yet? RAi builds one for you, structured to 21 CFR 820.30 design controls and ISO 13485. Already have Greenlight Guru, MasterControl, or Veeva? RAi reads from them and writes back. Either way, you're audit-ready.

🔒

Tamper-evident audit trail

Hash-chained audit log — change one row and the chain breaks visibly, so an inspector can verify integrity in seconds. 21 CFR Part 11 §11.50 electronic signatures bound to a specific document version. Every accept, reject, comment, approval, and login logged with user, timestamp, and reason. Export to a signed PDF for FDA inspection.

See it work.

Three moments from inside the app. The kind of work an RA/QA team used to outsource to consultants for $20–50K per submission — happening live, in the document, in seconds.

⚠ RAi Guard Pitfall Check

…The device safely and effectively treats is intended to detect chronic venous insufficiency…

⚠ RAi Guard · severity: critical
"Safely and effectively treats" is restricted FDA language. "Treats" also implies a therapeutic indication beyond your cleared diagnostic scope.
Source: FDA OPDP Communications guidance · 21 CFR 801.4
📚 RAi Citer Citation Suggester

Biocompatibility was demonstrated through cytotoxicity testing on the device contact materials.[insert cite]

📚 RAi found 2 supporting sources (confidence 0.91)
Standard
ISO 10993-5:2009 §8 — Test procedures for in vitro cytotoxicity
Your evidence
TR-2024-007.pdf §3.2 — Biocompatibility cytotoxicity test report
Auto-links to your traceability matrix on accept.
📊 Tracker Submission Tracker
Cardiac Stent Mk II · 510(k)
Predicted decision Aug 18, 2026
Pre-SubDraftingInternalSubmitted RTAAI HoldSubst.Decision
Submission readiness78%
Top gaps: Section 13 predicate table · Section 20 animal study · 2 "safe and effective" flags
📅 Timeline Portfolio Gantt
Submissions across the next 12 months · phase bars are derived from FDA-typical durations + RAi's predicted readiness
 
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Cardiac Stent Mk II
510(k) · K-pending
Pre-Sub
Drafting
Internal
RTA
Substantive
AI Hold
Subst.
◆ Aug 18
Insulin Delivery Pen v3
De Novo · 41 days in
Drafting (43% ready)
Internal
RTA
Substantive →
AI Triage Algorithm
510(k) + PCCP · 91% ready
Drafting
Internal
RTA
Substantive
◆ Sep 22
Today · May 24, 2026
Complete In progress AI Hold · clock paused Upcoming Predicted decision
Plus everything else: threaded comments, version history, electronic signatures bound to a specific document version, RAi-drafted AI-Hold responses, multi-reviewer workflows, project-task Gantt for the work behind each submission, and a live traceability matrix that builds itself as you write.

Plugs into the tools you already use.

No data migration. RAi reads from your existing systems in seconds.

Egnyte
Outlook
Greenlight Guru
MasterControl
Veeva Vault
SharePoint
Dropbox
Google Drive
Jira
Salesforce
Slack
API / custom

Simple pricing. Built for teams of every size.

Cancel anytime. Annual plans get two months free. Enterprise includes implementation services.

FDA Guide

$1,500/month

The AI regulatory consultant. For RA/QA teams who need cited answers, fast.

  • 1 user included (+$250/mo per extra user)
  • AI consultant with 21 CFR + FDA guidance corpus
  • Submission gap analysis (510(k), De Novo, IND)
  • Audit-ready, cited answer logs
  • Connect Egnyte, Outlook, SharePoint, Slack, Teams
  • 500 usage credits/mo · overages billed monthly
  • Priority email support
Start free trial →

Enterprise

Custom

For consultancies, large pharma, and multi-product portfolios.

  • Unlimited users & workspaces
  • Private deployment / VPC
  • 21 CFR Part 11 e-signatures bound to versioned documents
  • Full audit log with reason-for-signing capture (Part 11 §11.50)
  • Custom corpus (your SOPs, templates, predicate database)
  • SSO (SAML / Okta / Azure AD), SCIM, advanced RBAC
  • Custom usage credit volume
  • White-glove implementation + RA/QA migration services

All plans include cited answers, audit logs, and SOC 2 Type II security. Usage credits cover AI consultation, document analysis, and template generation. Overage rate $0.50 per credit. 14-day free trial on FDA Guide and QMS Suite. No setup fees.

Cut submission prep time by 60%.

Get a personalized walkthrough with one of our regulatory specialists. We'll show you RAi on your own SOPs and submissions, under NDA.